NeuroOne expands Zimmer Biomet distribution deal for OneRF Ablation System; $3M upfront

NEUROONE MEDICAL TECHNOLOGIES Corp

Zimmer Biomet gets exclusive US and certain OUS distribution rights for OneRF Ablation System.
NeuroOne receives $3M upfront within 10 business days plus up to $1M milestone payment.
OneRF is only FDA-cleared RF ablation system for both diagnostic and therapeutic brain use.
Agreement effective Oct 25, 2024, term to Sep 30, 2034 unless earlier terminated.
NeuroOne expects meaningful revenue and improved profitability from the agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.